Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Simons

Showing results (341-350 of 364) with videos related to

Pageof 37
Sort By:
Biorxiv : the Preprint Server for Biology|October 31, 2023
Convergent alterations in the tumor microenvironment of MYC-driven human and murine prostate cancerMindy K Graham, Rulin Wang, Roshan Chikarmane, et al.
Nature Communications|August 28, 2024
Convergent alterations in the tumor microenvironment of MYC-driven human and murine prostate cancerMindy K Graham, Rulin Wang, Roshan Chikarmane, et al.
Cancer Research|October 28, 1999
Induction of immunity to prostate cancer antigens: results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transferJ W Simons, B Mikhak, J F Chang, et al.
Cancer Chemotherapy and Pharmacology|August 19, 2000
Cancer cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer as vaccines for the treatment of genitourinary malignanciesW G Nelson, J W Simons, B Mikhak, et al.
Nature Communications|July 28, 2017
AIM1 is an actin-binding protein that suppresses cell migration and micrometastatic disseminationMichael C Haffner, David M Esopi, Alcides Chaux, et al.
JCO Precision Oncology|May 28, 2019
Genetic Alterations Detected in Cell-Free DNA Are Associated With Enzalutamide and Abiraterone Resistance in Castration-Resistant Prostate CancerSamantha Torquato, Aparna Pallavajjala, Alexa Goldstein, et al.
Nature Cancer|July 14, 2021
Accelerating precision medicine in metastatic prostate cancerJoaquin Mateo, Rana McKay, Wassim Abida, et al.
Cell|September 29, 2020
Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome in Children (MIS-C)Conor N Gruber, Roosheel S Patel, Rebecca Trachtman, et al.
Neoplasia (New York, N.Y.)|May 23, 2025
Twist1-induced suppression of oncogene-induced senescence in non-small cell lung cancer requires the transactivation domain of Twist1Audrey Lafargue, Hailun Wang, Sivarajan T Chettiar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2015
Germline Variants in Asporin Vary by Race, Modulate the Tumor Microenvironment, and Are Differentially Associated with Metastatic Prostate CancerPaula J Hurley, Debasish Sundi, Brian Shinder, et al.
Pageof 37

Showing results (341-350 of 364) with videos related to

Sort By:
Pageof 37
Biorxiv : the Preprint Server for Biology|October 31, 2023
Convergent alterations in the tumor microenvironment of MYC-driven human and murine prostate cancerMindy K Graham, Rulin Wang, Roshan Chikarmane, et al.
Nature Communications|August 28, 2024
Convergent alterations in the tumor microenvironment of MYC-driven human and murine prostate cancerMindy K Graham, Rulin Wang, Roshan Chikarmane, et al.
Cancer Research|October 28, 1999
Induction of immunity to prostate cancer antigens: results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transferJ W Simons, B Mikhak, J F Chang, et al.
Cancer Chemotherapy and Pharmacology|August 19, 2000
Cancer cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer as vaccines for the treatment of genitourinary malignanciesW G Nelson, J W Simons, B Mikhak, et al.
Nature Communications|July 28, 2017
AIM1 is an actin-binding protein that suppresses cell migration and micrometastatic disseminationMichael C Haffner, David M Esopi, Alcides Chaux, et al.
JCO Precision Oncology|May 28, 2019
Genetic Alterations Detected in Cell-Free DNA Are Associated With Enzalutamide and Abiraterone Resistance in Castration-Resistant Prostate CancerSamantha Torquato, Aparna Pallavajjala, Alexa Goldstein, et al.
Nature Cancer|July 14, 2021
Accelerating precision medicine in metastatic prostate cancerJoaquin Mateo, Rana McKay, Wassim Abida, et al.
Cell|September 29, 2020
Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome in Children (MIS-C)Conor N Gruber, Roosheel S Patel, Rebecca Trachtman, et al.
Neoplasia (New York, N.Y.)|May 23, 2025
Twist1-induced suppression of oncogene-induced senescence in non-small cell lung cancer requires the transactivation domain of Twist1Audrey Lafargue, Hailun Wang, Sivarajan T Chettiar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2015
Germline Variants in Asporin Vary by Race, Modulate the Tumor Microenvironment, and Are Differentially Associated with Metastatic Prostate CancerPaula J Hurley, Debasish Sundi, Brian Shinder, et al.
Pageof 37